+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 55Years +
All Genders
ID07144137

Observational Study of Short-Term Progression in Geographic Atrophy Related to Age-Related Macular Degeneration in Adults 55 and Older

Led by Complement Therapeutics · Updated on 2026-10-16

75

Participants Needed

19

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting an observational study to understand the short-term progression of geographic atrophy GA caused by age-related macular degeneration AMD in adults aged 55 and older. The goal is to identify participants with progressive GA and measure structural and functional changes, while exploring possible links to genetic and lifestyle factors. Participants will not receive any investigational treatments during this non-interventional study. Instead, their condition will be closely monitored over time using imaging techniques such as fundus autofluorescence FAF and optical coherence tomography OCT. The study will include assessments at baseline, month 3, and month 6 to track GA progression and related changes. Throughout the study, participants will undergo various eye examinations including visual acuity tests and microperimetry to measure retinal sensitivity. Researchers will collect data on GA progression and analyze correlations with genetic and lifestyle aspects. The study aims to provide detailed insight into GA changes over six months, with safety and adherence monitored by the research team. Participation will last approximately six months with scheduled visits for assessments.

CONDITIONS

Brief Title

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

Research Team

M

Muhammad Ali Memon

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here